MYC and Burkitt lymphoma: Among them, LBCL with IRF4 rearrangement (LBCL-IRF4) [17–19], and high-grade/large B-cell lymphoma with 11q aberration (HG/LBCL-11q) with features resembling Burkitt lymphoma (BL) without MYC-R, emerged as new entities in the 2022 International Consensus Classification (ICC) and in the 5th edition of the WHO classification [20–22].